ELMIRON (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the ELMIRON drug offered from Janssen Pharmaceuticals, Inc.. This Glycosaminoglycan [EPC],Glycosaminoglycans [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | PENTOSAN POLYSULFATE SODIUM |
SUBSTANCE NAME: | PENTOSAN POLYSULFATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glycosaminoglycan [EPC],Glycosaminoglycans [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, GELATIN COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1996-09-26 |
END MARKETING DATE: | 0000-00-00 |
ELMIRON HUMAN PRESCRIPTION DRUG Details:
Item Description | ELMIRON from Janssen Pharmaceuticals, Inc. |
LABELER NAME: | Janssen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 1996-09-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50458-098_c2e6eea1-81d2-4940-a173-5e454894317d |
PRODUCT NDC: | 50458-098 |
APPLICATION NUMBER: | NDA020193 |
Other PENTOSAN POLYSULFATE SODIUM Pharmaceutical Manufacturers / Labelers: